安神定志灵通过抗炎作用缓解注意缺陷多动障碍样症状
该研究在自发性高血压大鼠(SHR)ADHD模型中观察安神定志灵的作用及抗炎机制。SHR分为模型组、托莫西汀组(4.56 mg/kg/day)和安神定志灵组(21.25 g/kg/day),灌胃四周,Wistar Kyoto大鼠为对照。结果提示安神定志灵改善多动、冲动及空间记忆,降低促炎因子并升高IL-10,减少前额叶皮层和海马小胶质细胞、星形胶质细胞及肥大细胞活化,并通过保护血脑屏障完整性和抑制MAPK、NF-κB通路减轻神经炎症。
要点
- 安神定志灵可改善SHR大鼠多动、冲动及空间记忆。
- 安神定志灵降低IL-1β、IL-4、IL-6、TNF-α、MCP-1并升高IL-10。
- 其机制涉及保护血脑屏障及抑制MAPK、NF-κB通路。
核心结论
- 安神定志灵通过减轻神经炎症缓解SHR大鼠的ADHD样症状。
研究设计与样本
- 研究采用幼年自发性高血压大鼠(SHR)作为ADHD模型,设SHR模型组(溶媒)、托莫西汀组(4.56 mg/kg/day)和安神定志灵组(21.25 g/kg/day),灌胃四周,Wistar Kyoto大鼠为对照(溶媒)。
主要发现
- 安神定志灵显著控制SHR大鼠的多动和冲动,并改善其空间记忆(旷场实验和Morris水迷宫)。
- 安神定志灵降低SHR大鼠促炎因子IL-1β、IL-4、IL-6、TNF-α和MCP-1,升高抗炎因子IL-10。
- 安神定志灵减少SHR大鼠前额叶皮层和海马中小胶质细胞、星形胶质细胞和肥大细胞的活化。
- 安神定志灵通过保护血脑屏障完整性和抑制MAPK、NF-κB信号通路抑制神经炎症反应。
临床怎么用
- 该研究为安神定志灵治疗ADHD提供了抗神经炎症的临床前证据,支持其作为ADHD治疗处方的潜在价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Attention deficit hyperactivity disorder (ADHD) is a childhood-onset chronic neurobehavioral disorder, with multiple genetic and environmental risk factors. Chronic inflammation may be critical for the progression of ADHD. An Shen Ding Zhi Ling (ASDZL) decoction, a traditional Chinese medicine prescription, is clinically used in ADHD treatment. In this study, we investigated the effects and underlying anti-inflammatory mechanisms of ASDZL in young spontaneously hypertensive rats (SHRs), a widely used model of ADHD. SHRs were divided into the SHR model group (vehicle), atomoxetine group (4.56 mg/kg/day) and ASDZL group (21.25 g/kg/day), and orally administered for four weeks. Wistar Kyoto rats were used as controls (vehicle). We found that ASDZL significantly controlled hyperactivity and impulsivity, and improved spatial memory of SHRs in the open field test and Morris water maze test. ASDZL reduced the pro-inflammatory factors interleukin (IL)-1β, IL-4, IL-6, tumor necrosis factor (TNF)-α and monocyte chemoattractant protein (MCP)-1 and increased anti-inflammatory factor IL-10 in SHRs, and decreased the activation of microglia, astrocytes and mast cells in the prefrontal cortex (PFC) and hippocampus. Furthermore, the results indicated that ASDZL inhibited the neuroinflammatory response by protecting the integrity of the blood-brain barrier and suppressing the mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-κB signaling pathways of SHRs. In conclusion, these findings revealed that ASDZL attenuated ADHD symptoms in SHRs by reducing neuroinflammation.
引用
- Song Y, Yuan H, Chen T, et al. An Shen Ding Zhi Ling Alleviates Symptoms of Attention Deficit Hyperactivity Disorder via Anti-Inflammatory Effects in Spontaneous Hypertensive Rats. Front Pharmacol. 2021. PMID: 33536923. doi:10.3389/fphar.2020.617581
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。